Cargando…

Infiltrative hepatocellular carcinoma with multiple lung metastasis completely cured using nivolumab: a case report

The current Food and Drug Administration-approved systemic treatments for advanced hepatocellular carcinoma (HCC) include multikinase inhibitors (tyrosine kinase inhibitor [TKI]) and immune checkpoint inhibitors (ICIs). Among ICIs, nivolumab is used as second-line therapy for advanced HCC after sora...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Ji Eun, Cho, Hyo Jung, Kim, Soon Sun, Cheong, Jae Youn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Liver Cancer Association 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035689/ https://www.ncbi.nlm.nih.gov/pubmed/37383079 http://dx.doi.org/10.17998/jlc.2021.08.26

Ejemplares similares

A case of nearly complete response in hepatocellular carcinoma with disseminated lung metastasis by combination therapy of nivolumab and ipilimumab after treatment failure of atezolizumab plus bevacizumab
por: Kim, Hyung Jun, et al.
Publicado: (2023)

Role of Immune Cells in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma
por: Cho, Hyo-Jung, et al.
Publicado: (2021)

Circulating Exosomal MicroRNA-1307-5p as a Predictor for Metastasis in Patients with Hepatocellular Carcinoma
por: Eun, Jung Woo, et al.
Publicado: (2020)

Effect of direct-acting antivirals for hepatitis C virus-related hepatocellular carcinoma recurrence and death after curative treatment
por: Ahn, Young-Hwan, et al.
Publicado: (2022)

Nivolumab for Advanced Hepatocellular Carcinoma with Multiple Lung Metastases after Sorafenib Failure
por: Kim, Jaewoong, et al.
Publicado: (2020)

Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma
por: Lee, Han Ah, et al.
Publicado: (2021)

Complete cure of advanced hepatocellular carcinoma with right adrenal gland metastasis and portal vein thrombosis by multiple applications of an interdisciplinary therapy: Case report with 8-year follow up
por: Jung, Hojung, et al.
Publicado: (2018)

Tumor Endothelial Cells-Associated Integrin Alpha-6 as a Promising Biomarker for Early Detection and Prognosis of Hepatocellular Carcinoma
por: Kim, Hyung Seok, et al.
Publicado: (2023)

Serum Exosomal MicroRNA, miR-10b-5p, as a Potential Diagnostic Biomarker for Early-Stage Hepatocellular Carcinoma
por: Cho, Hyo Jung, et al.
Publicado: (2020)

Diffuse Interstitial Infiltrative Lung Metastasis of Malignant Melanoma: a Case Report
por: Shin, Na-young, et al.
Publicado: (2011)

MLH1 single-nucleotide variant in circulating tumor DNA predicts overall survival of patients with hepatocellular carcinoma
por: Kim, Soon Sun, et al.
Publicado: (2020)

Profiling of Exome Mutations Associated with Progression of HBV-Related Hepatocellular Carcinoma
por: Woo, Hyun Goo, et al.
Publicado: (2014)

Serum small extracellular vesicle‐derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma
por: Kim, Soon Sun, et al.
Publicado: (2020)

Pathway-Based Integrative Analysis of Metabolome and Microbiome Data from Hepatocellular Carcinoma and Liver Cirrhosis Patients
por: Kim, Boram, et al.
Publicado: (2020)

Circulating small extracellular vesicle-derived splicing factor 3b subunit 4 as a non-invasive diagnostic biomarker of early hepatocellular carcinoma
por: Son, Ju A, et al.
Publicado: (2023)

Pathological complete response with nivolumab for recurrence of liver metastasis after gastrectomy of gastric cancer
por: Jun, Chen, et al.
Publicado: (2023)

Novel Gene Signatures as Prognostic Biomarkers for Predicting the Recurrence of Hepatocellular Carcinoma
por: Son, Ju A, et al.
Publicado: (2022)

Aberrantly Expressed MicroRNAs in Cancer-Associated Fibroblasts and Their Target Oncogenic Signatures in Hepatocellular Carcinoma
por: Eun, Jung Woo, et al.
Publicado: (2023)

Lung brain metastasis pseudoprogression after nivolumab and ipilimumab combination treatment
por: Melian, Marcos, et al.
Publicado: (2018)

Hypomethylation-mediated upregulation of the WASF2 promoter region correlates with poor clinical outcomes in hepatocellular carcinoma
por: Ahn, Hye Ri, et al.
Publicado: (2022)

Nivolumab infusion reaction manifesting as plantar erythema and pulmonary infiltrate in a lung cancer patient
por: Ogawara, Daiki, et al.
Publicado: (2017)

Concomitant Subdural Hemorrhage and Intracerebral Hemorrhage due to Brain Metastasis of the Hepatocellular Carcinoma
por: Jang, Se Youn, et al.
Publicado: (2015)

Early detection of hepatocellular carcinoma via liquid biopsy: panel of small extracellular vesicle‐derived long noncoding RNAs identified as markers
por: Kim, Soon Sun, et al.
Publicado: (2021)

Broad-Spectrum Antibiotic Regimen Affects Survival in Patients Receiving Nivolumab for Non-Small Cell Lung Cancer
por: Geum, Min Jung, et al.
Publicado: (2021)

Hepatocellular Carcinoma with Distant Metastasis Cured by 20-Day Sorafenib Treatment
por: Kim, Seok Bae
Publicado: (2021)

Relationship between the dynamics of non-alcoholic fatty liver disease and incident diabetes mellitus
por: Han, Ji Eun, et al.
Publicado: (2022)

A case of multiple metastatic sarcomatoid renal cell carcinoma with complete response to nivolumab
por: Tomioka, Masayuki, et al.
Publicado: (2021)

Complete cure of a patient with HBV-associated hepatocellular carcinoma with lung metastasis using interferon and survival up to 108 months: A case report and literature review
por: Wang, Fang, et al.
Publicado: (2018)

Achievement of complete response to nivolumab in a patient with advanced sarcomatoid hepatocellular carcinoma: A case report
por: Zhu, Shu-Guang, et al.
Publicado: (2020)

Circulating Microbiota-Based Metagenomic Signature for Detection of Hepatocellular Carcinoma
por: Cho, Eun Ju, et al.
Publicado: (2019)

Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment
por: Lee, Cheol-Hyung, et al.
Publicado: (2020)

Diffuse Infiltrative Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Completely Cured by Transcatheter Arterial Chemoembolization: Case Report with 8-Year Follow-Up
por: Kim, Suk Bae
Publicado: (2016)

Low-dose nivolumab in advanced hepatocellular carcinoma
por: Chen, Yen-Hao, et al.
Publicado: (2022)

Exosomal microRNA‐4661‐5p–based serum panel as a potential diagnostic biomarker for early‐stage hepatocellular carcinoma
por: Cho, Hyo Jung, et al.
Publicado: (2020)

Bioelectrical impedance analysis for predicting postoperative complications and survival after liver resection for hepatocellular carcinoma
por: Lee, Gil Ho, et al.
Publicado: (2021)

Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients
por: Chung, Min-Woo, et al.
Publicado: (2021)

Risk Prediction Model Based on Magnetic Resonance Elastography-Assessed Liver Stiffness for Predicting Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma
por: Cho, Hyo Jung, et al.
Publicado: (2022)

Cancer‐associated fibroblast‐derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib
por: Eun, Jung Woo, et al.
Publicado: (2023)

The presence and size of intrahepatic tumors determine the therapeutic efficacy of nivolumab in advanced hepatocellular carcinoma
por: Kim, Han Sang, et al.
Publicado: (2022)

Ruptured Massive Hepatocellular Carcinoma Cured by Transarterial Chemoembolization
por: Lee, Ji Eun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sqlfv918odcnbpq3l7thio42g7